RBC Bioscience Corporation (TPEX:6848)
18.60
-1.45 (-7.23%)
Nov 20, 2026, 1:48 PM CST
| Market Cap | 265.49M +9.4% |
| Revenue (ttm) | 209.59M -0.6% |
| Net Income | 15.31M -29.0% |
| EPS | 1.07 -29.0% |
| Shares Out | 14.27M |
| PE Ratio | 17.43 |
| Forward PE | n/a |
| Dividend | 3.53 (19.00%) |
| Ex-Dividend Date | Sep 2, 2026 |
| Volume | 61,308 |
| Open | 19.15 |
| Previous Close | 20.05 |
| Day's Range | 18.40 - 19.30 |
| 52-Week Range | 14.30 - 28.15 |
| Beta | 0.44 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Apr 21, 2027 |